Fuel your journey with pure, potent, and science-backed support
In the SUSTAIN and SURMOUNT trials, gastrointestinal events occurred in 4060% of participants, with most reporting mild to moderate nausea, vomiting, or diarrhea that improved over time
Package included: 2Pack / 8Pcs * Patch
Tirzepatide is a multi-receptor agonist studied for its interaction with metabolic pathways
Beginning in early January, September, or springwhen motivation peaks and social eating occasions are fewercreates a natural advantage for habit formation
Despite receiving a combination of therapies, the cancers advanced stage and metastatic nature made treatment difficult, and Creel passed away in September 2024